Rekor Systems, Inc. (REKR) Stock Price & Analysis

Rekor Systems, Inc. (REKR) fell 3.48% to USD 0.71 as of June 10, 2026 at 02:14 UTC, according to Nexqual real-time market data.

REKR last closed at USD 0.74; the session ranged USD 0.69–0.76 on volume of 2,902,431 shares. Market capitalization is $98.03M, with a 52-week range of USD 0.69–3.42 (NCM). Source: Nexqual, June 10, 2026 at 02:14 UTC.

Key Statistics (as of June 10, 2026 at 02:14 UTC)

PriceUSD 0.71
Change▼ 3.48% (down)
Previous CloseUSD 0.74
OpenUSD 0.74
Day RangeUSD 0.69 – 0.76
52-Week RangeUSD 0.69 – 3.42
Volume2,902,431 shares
Market Cap$98.03M
ExchangeNCM

Technical Analysis (REKR)

Nexqual's technical model rates REKR "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:14 UTC.

Overall SignalSELL
RSI (14)38.11 (neutral)
vs SMA50Below (USD 0.82)
MACD-0.02 (negative)

Analyst Ratings (REKR)

Wall Street analysts rate REKR "None" based on 1 analysts, with a mean price target of USD 3 (range USD 3–3), per Nexqual as of June 10, 2026 at 02:14 UTC.

Consensus RatingNone
Analyst Count1
Mean TargetUSD 3
High TargetUSD 3
Low TargetUSD 3
Buy / Hold / Sell1 / 0 / 0

Earnings (REKR)

Next Earnings Date2026-05-11
Revenue Estimate$13.06M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD -0.07 vs est -0.04 ▼ miss
2025-12-31USD -0.04 vs est -0.03 ▼ miss
2025-09-30USD -0.03 vs est -0.04 ▲ beat
2025-06-30USD -0.07 vs est -0.05 ▼ miss

Source: Nexqual, June 10, 2026 at 02:14 UTC.

Financials & Fundamentals (REKR)

Total Revenue$49.52M
Revenue Growth (YoY)+11.60%
Gross Margin+56.58%
Operating Margin-85.91%
Profit Margin-60.48%
ROE-88.30%
Debt / Equity85.36
Current Ratio0.87
Total Cash$12.18M
Total Debt$29.42M
Free Cash Flow$-8.88M

Source: Nexqual, June 10, 2026 at 02:14 UTC.

Financial Health Score (REKR)

Nexqual rates Rekor Systems, Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:14 UTC.

GrowthSolid — Revenue +5% YoY (annual)
ProfitabilityWeak — Not yet profitable — scaling phase
Balance SheetWeak — $12M cash vs $29M debt
Cash FlowWeak — FCF negative: -$9M, burning cash
EfficiencyCritical — ROE -88%, ROA -18.8%

Ownership (REKR)

Insider Ownership+3.99%
Institutional Ownership+39.36%
Shares Outstanding137.61M
Float133.14M
Short % of Float+15.15%

Source: Nexqual, June 10, 2026 at 02:14 UTC.

Leadership (REKR)

Rekor Systems, Inc. is led by Robert Alan Berman (age 64), Founder, President, CEO & Executive Chairman, per Nexqual as of June 10, 2026 at 02:14 UTC.

Founder, President, CEO & Executive ChairmanRobert Alan Berman (age 64)
Chief Financial OfficerJoseph Nalepa (age 35)
Chief Technology OfficerChristopher Kadoch
Director of Investor RelationsBulent S. Ozcan C.F.A.
Executive Vice President of Government Relations & Corporate CommunicationsCharles A. Degliomini (age 66)

Major Backers & Investors (REKR)

Notable institutional backers of Rekor Systems, Inc. include UBS Group AG, Prescott Group Capital Management, L.L.C., Renaissance Technologies, according to Nexqual as of June 10, 2026 at 02:14 UTC.

Active Investors

InvestorStake
UBS Group AG1.86%
Prescott Group Capital Management, L.L.C.1.82%
Renaissance Technologies1.71%
Mercer Global Advisors, Inc./ADV1.24%
Qube Research & Technologies Ltd0.89%
Fidelity0.83%

Index Funds (Passive)

FundStake
Vanguard Group8.55%
State Street5.09%
BlackRock1.74%
Geode Capital0.95%

Source: Nexqual, June 10, 2026 at 02:14 UTC.

From Rekor Systems, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)

Key Strengths & Strategy (as disclosed to the SEC)

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
VERIVeritone, Inc.USD 1.61▼ 5.85%
LTRXLantronix, Inc.USD 6.37▼ 2.9%
NOTEFiscalNote Holdings, Inc.USD 0.18▲ 2.94%
RZLVRezolve AI PLCUSD 2.33▲ 1.3%
DVLTDatavault AI Inc.USD 0.4▼ 6.86%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:14 UTC. This page is informational and not investment advice.